Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Zoldhelyi

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
The Journal of Clinical Investigation|July 15, 1996
Adenoviral-mediated transfer of the human endothelial nitric oxide synthase gene reduces acute hypoxic pulmonary vasoconstriction in ratsS P Janssens, K D Bloch, Z Nong, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1995
Restoration of prostacyclin synthesis by transfer of prostaglandin H synthase cDNAK K Wu, P Zoldhelyi, J T Willerson, et al.
Circulation|December 1, 1994
Persistent thrombin generation in humans during specific thrombin inhibition with hirudinP Zoldhelyi, J Bichler, W G Owen, et al.
Texas Heart Institute Journal|January 1, 1994
Gene therapy for vascular diseasesK K Wu, P Zoldhelyi, J T Willerson, et al.
Zeitschrift Fur Kardiologie|February 24, 2001
[New antithrombotic therapy approaches in coronary heart disease--prospects for gene therapy]T W Jax, H C Eichstaedt, H S Shelat, et al.
Circulation|May 7, 1998
Human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in ratsS Janssens, D Flaherty, Z Nong, et al.
Seminars in Interventional Cardiology : SIIC|November 5, 1999
The emerging clinical potential of cardiovascular gene therapyP Zoldhelyi, H Eichstaedt, T Jax, et al.
Circulation|November 1, 1993
Recombinant hirudin in patients with chronic, stable coronary artery disease. Safety, half-life, and effect on coagulation parametersP Zoldhelyi, M W Webster, V Fuster, et al.
Circulation|February 7, 2001
Growth suppression of human coronary vascular smooth muscle cells by gene transfer of the transcription factor E2F-1H S Shelat, T J Liu, D L Hickman-Bick, et al.
Circulation|February 15, 1996
Does antithrombotic therapy influence residual thrombus after thrombolysis of platelet-rich thrombus? Effects of recombinant hirudin, heparin, or aspirinJ S Mruk, P Zoldhelyi, M W Webster, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
The Journal of Clinical Investigation|July 15, 1996
Adenoviral-mediated transfer of the human endothelial nitric oxide synthase gene reduces acute hypoxic pulmonary vasoconstriction in ratsS P Janssens, K D Bloch, Z Nong, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1995
Restoration of prostacyclin synthesis by transfer of prostaglandin H synthase cDNAK K Wu, P Zoldhelyi, J T Willerson, et al.
Circulation|December 1, 1994
Persistent thrombin generation in humans during specific thrombin inhibition with hirudinP Zoldhelyi, J Bichler, W G Owen, et al.
Texas Heart Institute Journal|January 1, 1994
Gene therapy for vascular diseasesK K Wu, P Zoldhelyi, J T Willerson, et al.
Zeitschrift Fur Kardiologie|February 24, 2001
[New antithrombotic therapy approaches in coronary heart disease--prospects for gene therapy]T W Jax, H C Eichstaedt, H S Shelat, et al.
Circulation|May 7, 1998
Human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in ratsS Janssens, D Flaherty, Z Nong, et al.
Seminars in Interventional Cardiology : SIIC|November 5, 1999
The emerging clinical potential of cardiovascular gene therapyP Zoldhelyi, H Eichstaedt, T Jax, et al.
Circulation|November 1, 1993
Recombinant hirudin in patients with chronic, stable coronary artery disease. Safety, half-life, and effect on coagulation parametersP Zoldhelyi, M W Webster, V Fuster, et al.
Circulation|February 7, 2001
Growth suppression of human coronary vascular smooth muscle cells by gene transfer of the transcription factor E2F-1H S Shelat, T J Liu, D L Hickman-Bick, et al.
Circulation|February 15, 1996
Does antithrombotic therapy influence residual thrombus after thrombolysis of platelet-rich thrombus? Effects of recombinant hirudin, heparin, or aspirinJ S Mruk, P Zoldhelyi, M W Webster, et al.
Pageof 3